Efficiency of montelukast in control of atopic diseases at children of preschool age


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The aim of study. To estimate clinical efficiency of the antagonist of the leukotriiene receptors - montelukast in control of atopic diseases at children of preschool age. Materials and methods. Open randomized comparative study of clinical efficiency of montelukast in parallel groups of children of preschool age having atopic diseases was conducted. Results. Inclusion of montelukast (singular) in basic therapy of children of preschool age, having atopic diseases, allowed to decrease the number of exacerbations of a bronchial asthma and allergic rhinitis and as well as the necessity of «emergency aid», when a dose of topical glucocorticosteroids reduced 1,9 times. Conclusion. Montelukast treatment showed high clinical efficiency and allowed to control symptoms of allergic rhinitis and bronchial asthma, when it was included in the basic therapy of atopic diseases at children of preschool age.

作者简介

N Volkova

Central Medical-Sanitary Department № 91 of the FMBA of Russia

Email: Volkov-vaa@yandex.ru
Lesnoy, Sverdlovsk region

E Beltyukov

Ural State Medical University Ministry of Health of Russia

Ekaterinburg

参考

  1. Геппе Н.А., Мокина Н.А., Малахова-Капанадзе М.А. Современные возможности применения антилейкотриеновых препаратов в терапии бронхиальной астмы у детей. Рос. Аллергол. Журн. 2007, № 3, прил. 1, с. 9.
  2. Bisgaard H., Zielen S., Garcia-Garcia M.L. et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Amer. J. Respir. Crit. Care Med. 2005, v. 171, р. 315-322.
  3. Lagos J.A., Marshall G.D. Montelukast in the management of allergic rhinitis. Ther. Clin. Risk. Manag. 2007, v. 3, р. 327-332.
  4. Phan H., Moeller M.L., Nahata M.C. Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast. Drugs. 2009, v. 69, р. 2541-2576.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pharmarus Print Media, 2015

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).